An open-label, randomized, single-center, two-period, phase I, crossover study of the effect of zibotentan (ZD4054) on the pharmacokinetics of midazolam in healthy male volunteers-Reference-Cited by-同舟云学术

An open-label, randomized, single-center, two-period, phase I, crossover study of the effect of zibotentan (ZD4054) on the pharmacokinetics of midazolam in healthy male volunteers

Published:2010-07 Issue:7 Volume:32 Page:1372-1386
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Tomkinson Helen K.,Kemp John V.,Wollseifen Thomas,Morris Thomas,Oliver Stuart D.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference32 articles.

1. Cancer statistics, 2009;Jemal;CA Cancer J Clin.,2009

2. Prostate cancer incidence and mortality rates and trends in the United States and Canada;McDavid;Public Health Rep.,2004

3. Therapeutic options in androgen-independent prostate cancer: Building on docetaxel;Petrylak;BJU Int.,2005

4. Mechanisms leading to the development of hormone-resistant prostate cancer;Kasper;Urol Clin North Am.,2006

5. Mechanisms leading to the development of hormone-resistant prostate cancer;Kasper;Urol Clin North Am.,2006

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Zibotentan Can Be Co‐administered with Contraceptives Containing Ethinyl Estradiol and Levonorgestrel: A Pharmacokinetic Drug–Drug Interaction Study;Clinical Pharmacology & Therapeutics;2024-04-30

2. π–π Noncovalent Interaction Involving 1,2,4- and 1,3,4-Oxadiazole Systems: The Combined Experimental, Theoretical, and Database Study;Molecules;2021-09-18

3. A physiologically based pharmacokinetic (PBPK) approach to evaluate pharmacokinetics in patients with cancer;Biopharmaceutics & Drug Disposition;2013-02-26

4. Single- and multiple-dose pharmacokinetics, safety and tolerability of zibotentan (ZD4054) in Chinese men with advanced solid tumors;Cancer Chemotherapy and Pharmacology;2012-05-22

5. Disposition and metabolism of the specific endothelin A receptor antagonist zibotentan (ZD4054) in healthy volunteers;Xenobiotica;2011-10-20